Nebracetam

Nebracetam is an investigational drug of the racetam family that is a M₁ acetylcholine receptor agonist in rats.[1] Its effects in humans have not been studied.

Nebracetam

Clinical data
ATC code	none
Legal status
Legal status	AU: S4 (Prescription only) US: Unscheduled Not FDA approved
Identifiers
IUPAC name (RS)-4-(Aminomethyl)-1-benzylpyrrolidin-2-one
CAS Number	97205-34-0
PubChem CID	65926
ChemSpider	59334
UNII	T30038QI8N
ChEMBL	ChEMBL2104682
Chemical and physical data
Formula	C12H16N2O
Molar mass	204.273 g·mol^−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES O=C2N(Cc1ccccc1)CC(C2)CN
InChI InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 Key:LCAFGJGYCUMTGS-UHFFFAOYSA-N
(what is this?)  (verify)

See also

• Piracetam
• Aniracetam
• Racetam

References

1. Takeo S, Hayashi H, Miyake K, Takagi K, Tadokoro M, Takagi N, Oshikawa S (June 1997). "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats". British Journal of Pharmacology. 121 (3): 477–84. doi:10.1038/sj.bjp.0701161. PMC 1564714. PMID 9179389.